ProShare Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$247K Sell
29,199
-6,057
-17% -$51.3K ﹤0.01% 1579
2025
Q1
$283K Sell
35,256
-9,332
-21% -$75K ﹤0.01% 1450
2024
Q4
$400K Buy
44,588
+10,771
+32% +$96.7K ﹤0.01% 1417
2024
Q3
$248K Buy
33,817
+6,850
+25% +$50.2K ﹤0.01% 1590
2024
Q2
$154K Sell
26,967
-7,497
-22% -$42.8K ﹤0.01% 1587
2024
Q1
$173K Buy
34,464
+2,873
+9% +$14.4K ﹤0.01% 1707
2023
Q4
$284K Buy
31,591
+4,624
+17% +$41.6K ﹤0.01% 1425
2023
Q3
$210K Buy
26,967
+100
+0.4% +$777 ﹤0.01% 1436
2023
Q2
$260K Buy
26,867
+1,194
+5% +$11.6K ﹤0.01% 1365
2023
Q1
$281K Sell
25,673
-3,341
-12% -$36.6K ﹤0.01% 1251
2022
Q4
$125K Buy
29,014
+2,290
+9% +$9.89K ﹤0.01% 1599
2022
Q3
$202K Buy
26,724
+620
+2% +$4.69K ﹤0.01% 1403
2022
Q2
$262K Buy
26,104
+11,444
+78% +$115K ﹤0.01% 1290
2022
Q1
$181K Sell
14,660
-3,601
-20% -$44.5K ﹤0.01% 1906
2021
Q4
$418K Sell
18,261
-9,168
-33% -$210K ﹤0.01% 1578
2021
Q3
$607K Buy
27,429
+4,402
+19% +$97.4K ﹤0.01% 1094
2021
Q2
$298K Buy
23,027
+5,394
+31% +$69.8K ﹤0.01% 1903
2021
Q1
$229K Sell
17,633
-1,900
-10% -$24.7K ﹤0.01% 1961
2020
Q4
$270K Sell
19,533
-812
-4% -$11.2K ﹤0.01% 1675
2020
Q3
$300K Buy
20,345
+2,347
+13% +$34.6K ﹤0.01% 1174
2020
Q2
$292K Buy
17,998
+3,235
+22% +$52.5K ﹤0.01% 1244
2020
Q1
$214K Sell
14,763
-5,634
-28% -$81.7K ﹤0.01% 986
2019
Q4
$413K Sell
20,397
-4,453
-18% -$90.2K ﹤0.01% 1164
2019
Q3
$133K Sell
24,850
-1,979
-7% -$10.6K ﹤0.01% 1509
2019
Q2
$177K Sell
26,829
-2,156
-7% -$14.2K ﹤0.01% 1462
2019
Q1
$188K Buy
28,985
+62
+0.2% +$402 ﹤0.01% 1488
2018
Q4
$197K Sell
28,923
-5,415
-16% -$36.9K ﹤0.01% 1378
2018
Q3
$228K Sell
34,338
-1,046
-3% -$6.95K ﹤0.01% 1517
2018
Q2
$199K Sell
35,384
-3,477
-9% -$19.6K ﹤0.01% 1614
2018
Q1
$202K Buy
38,861
+10,078
+35% +$52.4K ﹤0.01% 1542
2017
Q4
$130K Buy
+28,783
New +$130K ﹤0.01% 1710